Eqalix, Inc

WILMINGTON, NC: Eqalix, Inc, an emerging biotechnology company in the Regenerative Medicine space is scheduled to present at the 11th annual BIO Investor Forum in San Francisco at the Palace Hotel.

A trio of tissue engineering technologies developed by researchers and clinicians from Drexel, Penn and CHOP are moving one step closer to becoming viable options for vascular surgery, skin replacement and tissue regeneration.